| |
|
|
Session 107
Poster Presentations Prevention of Perinatal Transmission (MTCT) Wednesday 1:30 - 3:30 pm Hall B |
| 851 | Effective Point-of-Care Rapid HIV Testing at Labor and Delivery M. H. Cohen*1, B. Branson2, Y. Olszewski1, M. Robey1, F. Love1, D. Jamieson2, M. Bulterys2 1CORE Ctr, Chicago, IL and 2CDC, Atlanta, GA |
| 852 | Trust Me, I'm a Doctor: Issues Related to Study Participation, Adherence, and Informed Consent in a Clinical Trial to Prevent Mother-to-Child Transmission of HIV through Breastfeeding A. Corneli1, E. Piwoz2, M. Bentley1, A. Moses3, Y. Ahmed4, A. Duerr4, C. van der Horst*1 1Univ of North Carolina, Chapel Hill; 2Academy for Ed Development, Washington, DC; 3Univ of North Carolina Project, Lilongwe, Malawi; and 4CDC, Atlanta, GA |
| 853 | Simplification of Neonatal Component of Regimens to Prevent Perinatal HIV Transmission M. O'Meara*, M. Goode, E. Hayes, K. Butler Our Lady's Hosp, Dublin, Ireland |
| 854 | A Short Course of Zidovudine + Peripartum Nevirapine is Highly Efficacious in Preventing Mother-to-Child Transmission of HIV-1: The ANRS 1201 DITRAME-plus Study, Abidjan, Côte d’Ivoire F. Dabis*1, D. K. Ekouevi2,3, L. Bequet2,3, F. Rouet2,3, A. Horo4, P. Fassinou4, L. Dequae-Merchadou1, V. Leroy1, ANRS PACCI DITRAME Plus Study Group2,3 1INSERM U330, Bordeaux, France; 2Agence Natl de Res sur le SIDA, Paris, France; 3PACCI, Abidjan, Cote d'Ivoire, South Africa; and 4CHU Yopougon, Abidjan, Cote d'Ivoire |
| 855 | Resistance Mutations Following a Single-dose Intrapartum Administration of Nevirapine to HIV-infected Thai Women and Their Infants Receiving Short-course Zidovudine T. Chaowanachan*1, T. Chotpitayasunondh2, N. Vanprapar3, W. Leelawiwat1, M. Culnane1,4, B. Jetsawang1, T. Tasaneeyapan1, P. Mock1, J. W. Tappero1,4, RJ Simonds 4 1Thailand MOPH-U S CDC Collaboration, Nonthaburi; 2Queen Sirikit Natl Inst of Child Hlth, Bangkok, Thailand; 3Siriraj Hosp, Mahidol Univ, Bangkok, Thailand; and 4CDC, Atlanta, GA |
| 856 | Analysis of Nevirapine Resistance Seven Days after Single-dose Nevirapine Prophylaxis: HIVNET 012 S. H. Eshleman*1, S. P. Cunningham1, D. Jones1, A. Mwatha2, E. R. Brown3, C. Mulvey1, L. A. Guay1, P. Musoke4, F. Mmiro4, J. B. Jackson1 1Johns Hopkins Med Inst, Baltimore, MD; 2Fred Hutchinson Cancer Res Ctr, Seattle, WA; 3Univ of Washington, Seattle; and 4Makerere Univ, Kampala, Uganda |
| 857 | Extended Analysis of Nevirapine Resistance in Women with Subtype A vs D HIV-1 6 S. H. Eshleman*1, L. A. Guay1, A. Mwatha2, T. Fleming3, S. P. Cunningham1, P. Musoke4, F. Mmiro4, J. B. Jackson1 1Johns Hopkins Med Inst, Baltimore, MD; 2Fred Hutchinson Cancer Res Ctr, Seattle, WA; 3Univ of Washington, Seattle; and 4Makerere Univ, Kampala, Uganda |